These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27622314)

  • 21. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F; Karabin B; Mehdirad A
    Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract]   [Full Text] [Related]  

  • 22. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH; Kinter CW; Wight J; Neelam AR; Krakow D
    J Med Case Rep; 2020 Jun; 14(1):73. PubMed ID: 32560740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
    Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
    Freeman R; Landsberg L; Young J
    Neurology; 1999 Dec; 53(9):2151-7. PubMed ID: 10599797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.
    Okamoto LE; Shibao CA; Gamboa A; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
    Hypertension; 2019 Jan; 73(1):235-241. PubMed ID: 30571543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure circadian rhythm alterations in alpha-synucleinopathies.
    Vallelonga F; Di Stefano C; Merola A; Romagnolo A; Sobrero G; Milazzo V; Burrello A; Burrello J; Zibetti M; Veglio F; Maule S
    J Neurol; 2019 May; 266(5):1141-1152. PubMed ID: 30783749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury.
    Wecht JM; Rosado-Rivera D; Weir JP; Ivan A; Yen C; Bauman WA
    Arch Phys Med Rehabil; 2013 Oct; 94(10):2006-12. PubMed ID: 23602882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
    Loavenbruck A; Sandroni P
    Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
    Pérez-Lloret S; Quarracino C; Otero-Losada M; Rascol O
    Expert Opin Pharmacother; 2019 Apr; 20(6):635-645. PubMed ID: 30730771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Droxidopa in neurogenic orthostatic hypotension.
    Kaufmann H; Norcliffe-Kaufmann L; Palma JA
    Expert Rev Cardiovasc Ther; 2015; 13(8):875-91. PubMed ID: 26092297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).
    Isaacson S; Shill HA; Vernino S; Ziemann A; Rowse GJ
    J Parkinsons Dis; 2016 Oct; 6(4):751-759. PubMed ID: 27636856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D; Lew M; Claassen D; Goodman BP
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract]   [Full Text] [Related]  

  • 39. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension.
    Tsioufis C; Syrseloudis D; Dimitriadis K; Thomopoulos C; Tsiachris D; Pavlidis P; Selima M; Kallikazaros I; Stefanadis C
    J Hum Hypertens; 2008 Jul; 22(7):501-8. PubMed ID: 18385743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone.
    Hakamäki T; Rajala T; Lehtonen A
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):367-9. PubMed ID: 9707350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.